Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services... see more

NDAQ:VMD - Post Discussion

Viemed Healthcare Inc > Conference call ?
View:
Post by checkup on Nov 02, 2022 1:41pm

Conference call ?

Anyone have thoughts or information on the conference call?   Market is just paying attention to the Fed meeting likely.
Comment by Carlito3211 on Nov 02, 2022 1:54pm
Callers seemed pleased with the results and said so. Hoyt made mention of a contract they have signed with the VA and talked about the progress they have made with that file. He never went into much detail about it though, and it would have been helpful if he did but thats always been their style. Stay under the radar it seems. I dont recall that I've seen any news about the VA in regards to ...more  
Comment by LongTerm3 on Nov 02, 2022 3:30pm
23 new areas this year so far. In January they predicted 25 for the whole year. VMD is ahead of schedule. Staffing, Sleep, and Oxygen doing good. M and A moving forward, in coming quarters Estimated rate increase of 8 percent for inflation in January. Lower cost for supplies.  67 percent vents. Patient count over 9,100   Revenue almost 36 million. Both are gaining.
Comment by Tropicalsun on Nov 02, 2022 6:28pm
Overall what is not to like about these financial numbers released for the 3rd quarter. Viemed is firing on all cylinders during tough inflationary times as well as economic constraints. Yes SG and A expenses are up again modestly, however that is to be expected with a growing company along with rising costs for just about everything. Todd provided a good explanation to this question. Reading ...more  
Comment by LongTerm3 on Nov 02, 2022 7:29pm
I would have to listen again, but I believe they did get awarded a solicitation contract from the VA to place people with patients and track their results.
Comment by checkup on Nov 02, 2022 8:07pm
Yes they did.  
Comment by Carlito3211 on Nov 03, 2022 10:24am
You pondered why no analyst asked any questions about the VA contract. Probably because it was the first they had heard the news and had no questions prepared for it. Thats these guys style. Happen to throw some news into the CC and it comes as a surprise to everyone. All the other usual growth numbers and good stuff are just all par for the course with this company. The news from Q to Q never ...more  
Comment by lscfa on Nov 02, 2022 5:16pm
Transcript......     https://seekingalpha.com/article/4552227-viemed-healthcare-inc-vmd-q3-2022-earnings-call-transcript
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities